Drug Type Biological products |
Synonyms AGT-110 |
Target |
Action inhibitors |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 1 | United States | 28 Oct 2021 | |
Amyotrophic Lateral Sclerosis | Phase 1 | United States | 28 Oct 2021 | |
Parkinson Disease | Phase 1 | United States | 28 Oct 2021 | |
Stroke | Phase 1 | United States | 28 Oct 2021 |